quinazolines has been researched along with Escherichia coli Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corriden, R; Griffin, JH; Gupta, N; Liu, R; Nizet, V; Pogliano, J; Pogliano, K; Shin, S; Sinha, R | 1 |
| Aoi, H; Boriack-Sjodin, PA; Doig, P; Dumas, J; Hu, J; Itoh, K; Johnson, K; Kazmirski, S; Kinoshita, T; Kuroda, S; Sato, TO; Sugimoto, K; Tohyama, K; Wakamatsu, K; Wang, H | 1 |
| Malaviya, R; Navara, C; Uckun, FM | 1 |
| Bowden, K; Harris, NV; Smith, C | 1 |
4 other study(ies) available for quinazolines and Escherichia coli Infections
| Article | Year |
|---|---|
SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity.
Topics: Animals; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Lung; Male; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia, Bacterial; Pyrroles; Quinazolines; Reactive Oxygen Species; Receptor, PAR-1 | 2018 |
Rational design of inhibitors of the bacterial cell wall synthetic enzyme GlmU using virtual screening and lead-hopping.
Topics: Animals; Anti-Bacterial Agents; Cell Wall; Drug Design; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Haemophilus Infections; Haemophilus influenzae; Humans; Molecular Docking Simulation; Multienzyme Complexes; Quinazolines | 2014 |
Augmentation of mast cell bactericidal activity by the anti-leukemic drug, 4-(3'bromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline.
Topics: Adjuvants, Immunologic; Animals; Cells, Cultured; Drug Evaluation, Preclinical; Escherichia coli; Escherichia coli Infections; Male; Mast Cells; Mice; Mice, Inbred BALB C; Peritonitis; Phagocytosis; Quinazolines; Specific Pathogen-Free Organisms | 2002 |
Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines.
Topics: Animals; Anti-Bacterial Agents; Cattle; Chemical Phenomena; Chemistry; Escherichia coli; Escherichia coli Infections; Folic Acid Antagonists; Liver; Mice; Molecular Structure; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship | 1990 |